Will oral rivaroxaban improve clinically re... [J Thromb Haemost. 2009] - PubMed

Save items

loading

Related citations in PubMed

Review Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery. [Ann Pharmacother. 2010]
Review Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery.
Melillo SN, Scanlon JV, Exter BP, Steinberg M, Jarvis CI. Ann Pharmacother. 2010 Jun; 44(6):1061-71. Epub 2010 Apr 27.
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. [Circulation. 2006]
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Muehlhofer E, Dierig C, Misselwitz F, Kälebo P, et al. Circulation. 2006 Nov 28; 114(22):2374-81. Epub 2006 Nov 20.
Review A logical approach to surgical thromboprophylaxis. [Curr Opin Hematol. 2009]
Review A logical approach to surgical thromboprophylaxis.
Lepic K, Crowther MA. Curr Opin Hematol. 2009 Sep; 16(5):397-401.
Review Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty. [Expert Opin Pharmacother. 2009]
Review Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty.
Borris LC. Expert Opin Pharmacother. 2009 Apr; 10(6):1083-8.
Review Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor. [Semin Thromb Hemost. 2007]
Review Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Laux V, Perzborn E, Kubitza D, Misselwitz F. Semin Thromb Hemost. 2007 Jul; 33(5):515-23.

See reviews... See all...

Cited by 1 PubMed Central article

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. [Vasc Health Risk Manag. 2012]
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
Dahl OE. Vasc Health Risk Manag. 2012; 8:45-57. Epub 2012 Jan 25.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxi...
Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
J Thromb Haemost. 2009 Dec ;7(12):2149-50. Epub 2009 Sep 18 .

PubMed
Oct-6: a POU transcription factor expressed in embryonal stem cells and in the d...
Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain.
EMBO J. 1990 Nov ;9(11):3723-32.

PubMed
The epidemiology of stroke in Pakistan: past, present, and future.
The epidemiology of stroke in Pakistan: past, present, and future.
Int J Stroke. 2009 Oct ;4(5):381-9.

PubMed
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA...
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity.
EMBO J. 1990 Nov ;9(11):3631-9.

PubMed
Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: im...
Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement.
Int J Exp Pathol. 2009 Oct ;90(5):549-57.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information